In Brief This Week: Abbott; Bio-Rad Laboratories; Prometheus Laboratories; GeneGo, Sigma-Aldrich; Fluidigm | GenomeWeb

NEW YORK (GenomeWeb News) – Abbott received CE Marking in the European Union for its RealTime mS9 Colorectal cancer test, a non-invasive DNA assay that detects the methylated form of Septin 9. The assay, which runs on Abbott's m2000 PCR-based molecular diagnostic system, can be used by physicians to determine if a patient should be referred for colonoscopy. The test is not available for sale in the US, the firm noted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.